| Axon ID |
Name |
Description |
From price |
|
1251
|
GW 441756
|
TrkA inhibitor |
€75.00 |
|
1394
|
Imatinib mesylate
|
Bcr-Abl, c-KIT and PDGFR kinase inhibitor |
€60.00 |
|
1398
|
Sunitinib malate
|
Multi-targeted receptor tyrosine kinase inhibitor |
€80.00 |
|
1411
|
Vandetanib
|
VEGFR and EGFR tyrosine kinase inhibitor |
€50.00 |
|
1414
|
AG 013736
|
PDGFR,c-KIT and VEGFR tyrosine kinase inhibitor |
€50.00 |
|
1415
|
CT 53518
|
PDGFR, c-KIT and FLT3 tyrosine kinase inhibitor |
€70.00 |
|
1419
|
AB 1010
|
PDGFR, c-KIT and FGFR3 tyrosine kinase inhibitor |
€70.00 |
|
1420
|
Pazopanib hydrochloride
|
PDGFR, c-KIT and VEGFR tyrosine kinase inhibitor |
€60.00 |
|
1461
|
Cediranib
|
VEGFR tyrosine kinase inhibitor |
€70.00 |
|
1547
|
OSI 930
|
c-Kit and VEGFR2 tyrosine kinase inhibitor |
€90.00 |
|
1610
|
AZ 23
|
TrkA and TrkB inhibitor |
€80.00 |
|
1637
|
Vatalanib
|
VEGFR tyrosine kinase inhibitor |
€75.00 |
|
1638
|
ABT 869
|
PDGFR, c-KIT and VEGFR tyrosine kinase inhibitor |
€85.00 |
|
1653
|
AEE 788
|
EGFR, ErbB2 and VEGFR tyrosine kinase inhibitor |
€80.00 |
|
1662
|
CP 547632
|
VEGFR2 tyrosine kinase inhibitor |
€70.00 |
|
1678
|
Regorafenib
|
Multi-kinase RTK inhibitor |
€70.00 |
|
1696
|
Quizartinib dihydrochloride
|
FLT3 inhibitor |
€90.00 |
|
1717
|
Tivozanib
|
VEGFR1, 2, and 3 tyrosine kinase inhibitor |
€80.00 |
|
1768
|
AMG 706
|
Multiple receptor tyrosine kinase inhibitor |
€105.00 |
|
1819
|
Cabozantinib S-malate
|
Inhibitor of multiple receptor tyrosine kinases, specifically MET and VEGFR2 |
€60.00 |
|
1850
|
BMS 540215
|
Inhibitor of VEGFR (subtype 2 and 3 selective) |
€110.00 |
|
1864
|
Brivanib alaninate
|
Prodrug of BMS 540215; Inhibitor of VEGF |
€90.00 |
|
1891
|
SU 6668
|
Inhibitor of RTK targeting PDGFR, VEGF and FGFR |
€100.00 |
|
1942
|
E 3810 dihydrochloride
|
Dual VEGFR/FGFR tyrosine kinase inhibitor |
€90.00 |
|
1946
|
R 428 dihydrochloride
|
Selective inhibitor of Axl receptor tyrosine kinases |
€80.00 |
|
1959
|
Golvatinib
|
Potent and orally available inhibitor of c-MET (HGFR) and VEGFR2 |
€90.00 |
|
1963
|
LY 573636
|
Anti-tumor agent; causes growth arrest and apoptosis |
€80.00 |
|
1978
|
ZM 323881 hydrochloride
|
Inhibitor of VEGFR2 |
€105.00 |
|
2023
|
PF 03814735
|
ATP-competitive inhibitor of aurora kinase A and B |
€120.00 |
|
2086
|
UNC569
|
Reversible and ATP-competitive inhibitor of Mer (RTK) |
€95.00 |
|
2089
|
7,8-Dihydroxyflavone
|
Tyrosine kinase receptor B (TrkB) agonist |
€55.00 |
|
2248
|
GNF 5837
|
Potent, selective, and orally bioavailable tropomyosin receptor kinase (Trk) inhibitor |
€90.00 |
|
1892
|
1-NM-PP1
|
Potent tyrosine kinase inhibitor (TKI) of multiple targets (Src, Fyn, Abl, CDK, Trk) |
€95.00 |
|
1667
|
SU 5402
|
Fibroblast growth factor receptor (FGFR) inhibitor |
€60.00 |
|
2265
|
DDR1-IN-1
|
Selective DDR1 receptor tyrosine kinase (RTK) inhibitor |
€95.00 |
|
2346
|
UNC2250
|
Potent Mer kinase inhibitor with promising selectivity and PK properties. |
€80.00 |
|
2368
|
Amuvatinib
|
RTK inhibitor which effectively inhibits PDGFR, c-Kit and c-Met |
€105.00 |
|
5006
|
Stem Cell CSD inhibitor Set
|
Set of CHIR99021, SU5402, and DAPT, inhibitors of GSK-3, FGFR, and γ-secretase, resp. |
€140.00 |
|
5007
|
Stem Cell 5i inhibitor Set
|
Set of five inhibitors for neural differentiation of human pluripotent stem cells. |
€200.00 |
|
2468
|
ANA 12
|
Selective TrkB antagonist with anxiolytic and antidepressant activity in mice |
€90.00 |
|
2501
|
Pexidartinib
|
Mutil-targeted RTK inhibitor of CSF1R, c-Kit, and FLT3 |
€60.00 |
|
2553
|
LY 2801653
|
Orally bioavailable multi-kinase inhibitor with potent activity against c-MET |
€120.00 |
|
2648
|
Nintedanib
|
RTK inhibitor with antiangiogenic and antineoplastic activities |
€70.00 |
|
2767
|
SU11652
|
Multi-targeted receptor tyrosine kinase inhibitor |
€140.00 |
|
2849
|
Apatinib
|
Inhibitor of VEGFR2 |
€120.00 |
|
2865
|
NVP-ACC789
|
Inhibitor of VEGFR2 |
€90.00 |
|
2837
|
BMS 605541
|
Potent, selective, orally active, and ATP-competitive VEGFR2 inhibitor |
€90.00 |
|
2978
|
Brigatinib
|
Potent, selective, and orally active anaplastic lymphoma kinase (ALK) inhibitor |
€80.00 |
|
3165
|
Lenvatinib
|
Multi-targeted receptor tyrosine kinase inhibitor |
€70.00 |
|
3407
|
LOXO-101 sulfate
|
First-in-class, potent, highly selective and ATP-competitive TRK inhibitor |
€80.00 |
|
3338
|
Taxifolin
|
Inhibitor of VEGFR2 |
€50.00 |
|
3624
|
Toceranib phosphate
|
Multi-targeted receptor tyrosine kinase inhibitor |
€60.00 |
|
3775
|
TrkB agonist prodrug R13
|
Prodrug of 7,8-Dihydroxyflavone; TrkB agonist |
€120.00 |
|
3901
|
LOXO-195
|
Trk inhibitor |
Inquire |
|
3946
|
Altiratinib
|
Balanced inhibitor for MET, TIE2 (TEK), and VEGFR2 (KDR) kinases |
Inquire |
|
3969
|
Crenolanib
|
Selective small molecule inhibitor of PDGFRα, PDGFRβ and FLT3. |
Inquire |
|
3975
|
MGCD265 dihydrochloride
|
Orally active, potent MET/SMO dual inhibitor |
€130.00 |
|
4073
|
CYC-116
|
Aurora kinases A & B and VEGFR2 inhibitor |
Inquire |